Tempus AI, Inc Class A Common Stock

Yahoo Finance • 15 hours ago

Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Gilead Sciences Inc. (NASDAQ:GILD) is one of the best quality stocks to buy according to hedge funds. On April 9, Tempus AI (NASDAQ:TEM... Full story

Yahoo Finance • 4 days ago

Meet Cathie Wood's Flagship Ark Innovation ETF, Which Has Crushed the S&P 500 Over the Last 12 Months

Ark Investment Management operates a dozen exchange-traded funds (ETFs) that invest in companies that are pursuing innovations across an array of technologies. Some of these funds have a specific focus in areas like artificial intelligence... Full story

Yahoo Finance • 4 days ago

Tempus AI Expands Collaboration With Gilead Sciences To Maximize Insights In Oncology Pipeline

(RTTNews) - Healthcare technology company Tempus AI, Inc. (TEM) Thursday announced an expanded, multi-year collaboration with Gilead Sciences, Inc. (GILD) to build and advance its oncology pipeline. As per the expanded agreement, Tempus A... Full story

Yahoo Finance • 10 days ago

Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

Cathie Wood’s ARK Invest funds have delivered mixed performance in the recent period, with ARK Space & Defense Innovation ETF (ARKX [https://seekingalpha.com/symbol/ARKX]) up 1.27% and ARK Autonomous Technology & Robotics ETF (ARKQ [https:... Full story

Yahoo Finance • 12 days ago

Assessing Tempus AI (TEM) Valuation After ALERT Cardiology Trial Results And Expanded Merck Collaboration

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Tempus AI (TEM) is back in focus after new data from its ALERT car... Full story

Yahoo Finance • 13 days ago

Jim Cramer on Tempus AI: “It’s a Decent Spec, I Would Hold on to Some, But Not All”

Jim Cramer gave top insight on Tempus AI, Inc. (NYSE:TEM), sharing a game plan of what to buy, sell, and hold right now. During the lightning round, a caller inquired if there is any future for the stock, and here’s what Cramer had to say... Full story

Yahoo Finance • 13 days ago

2 AI Healthcare Stocks to Buy Right Now

While the advent of artificial intelligence (AI) has obviously changed the world, not every utilization of AI has necessarily made the world a better place. Indeed, a recent survey from PwC indicates that 56% of CEOs aren't yet seeing any... Full story

Yahoo Finance • 17 days ago

Cathie Wood sells $2.1 million of megacap tech stock

Cathie Wood just dialed back one of Big Tech’s biggest names again. The ARK Invest boss shed 3,578 shares of Meta Platforms (META) on March 25, a move worth nearly $2.1 million. The sale was spread across three of ARK’s major actively ma... Full story

Yahoo Finance • 17 days ago

Cathie Wood Dumps $2.1 Million in This 'Magnificent Seven' Stock

This article first appeared on GuruFocus. Cathie Wood's ARK Invest sold shares of Meta Platforms (NASDAQ:META) and added to its position in Tempus AI (NASDAQ:TEM). The investment firm offloaded 3,578 Meta shares valued at about $2.1 mill... Full story

Yahoo Finance • 18 days ago

How The Tempus AI (TEM) Narrative Is Shifting On Growth Potential Versus Execution Risk

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Tempus AI sits in the middle of a wide price target range, with some recent bullish initiations reaching up to US$100 per s... Full story

Yahoo Finance • 21 days ago

Tempus AI Inc. (TEM) Touted as a Buy Amid Focus on Healthcare Opportunities

Tempus AI, Inc. (NASDAQ:TEM) is one of the top Robinhood stocks with high potential. On March 10, H.C. Wainwright reiterated a Buy rating on Tempus AI, Inc. (NASDAQ:TEM) and raised the price target to $95 from $89.Tempus AI Inc. (TEM) Tout... Full story

Yahoo Finance • 23 days ago

Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years.

Key Points Recursion is using AI to develop new drug candidates much more efficiently than the overall industry. Tempus AI's $1.27 billion trailing revenue comes from a clinical data flywheel that no competitor can build from scratch.10 s... Full story

Yahoo Finance • 24 days ago

H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95

Tempus AI, Inc. (NASDAQ:TEM) is among the 10 Best New AI Stocks to Buy. On March 9, H.C. Wainwright analyst Yi Chen raised the firm’s price target on Tempus AI, Inc. (NASDAQ:TEM) to $95 from $89 while maintaining a Buy rating. The analyst... Full story

Yahoo Finance • 27 days ago

Is Tempus AI (TEM) The Best AI Healthcare Stock in Cathie Wood’s Portfolio?

Tempus AI (NASDAQ:TEM) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Tempus AI (NASDAQ:TEM) uses AI to analyze and process large datasets to find patterns that help doctors treat patients more efficiently. ARK increased... Full story

Yahoo Finance • 29 days ago

Cathie Wood buys $2 million of tumbling AI stock

Cathie Wood, chief of Ark Investment Management, doesn’t give up on her favorite stocks easily. That’s what she just did, buying one of her top holdings that’s down 15% year-to-date. Wood gained a reputation after the flagship Ark Innova... Full story

Yahoo Finance • last month

Cathie Wood buys $27 million of battered tech stock

Cathie Wood, head of Ark Investment Management, likes to make bold bets, even when the stocks she picks are down for a while. That’s what she just did, buying a stock that’s down more than 30% year to date. Wood often views sharp pullbac... Full story

Yahoo Finance • last month

Assessing Tempus AI (TEM) Valuation After Expanded Merck Collaboration Announcement

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Tempus AI (TEM) is back in focus after announcing an expanded multi year collaboration with Merc... Full story

Yahoo Finance • last month

Tempus AI Deepens Merck Collaboration As Pharma Demand And Losses Evolve

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Tempus AI and Merck announced an expanded multi year collaboration focused on AI driven precision medicine and drug di... Full story

Yahoo Finance • last month

Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine

Tempus AI, Inc. (NASDAQ:TEM) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026. On March 3, the company announced a strategic partnership with Merck to fast-track the development of AI-driven precision medicine and suppo... Full story

Yahoo Finance • last month

Merck to collaborate with Tempus AI on precision oncology

[Merck Researches Laboratories in South San Francisco] hapabapa * Merck (MRK [https://seekingalpha.com/symbol/MRK]) has brokered a collaboration with Tempus AI (TEM [https://seekingalpha.com/symbol/TEM]) that is designed to bolster the... Full story